Should We Continue to Use the Cockcroft-Gault Formula?

Abstract

Background/Aims: Although the National Kidney Disease Education Program recommends use of the modification of diet in renal disease (MDRD) formula to estimate the glomerular filtration rate (GFR), most drug-dosing recommendations and clinical practices employ the Cockcroft-Gault (CG) formula. The quality score of the original MDRD study was better than that of the original CG study, although the imprecision sources were very similar between the formulas. To address whether CG should be abandoned in favour of MDRD in chronic kidney disease (CKD) management, we performed a literature review on the topic. Methods: We reviewed 27 articles comparing CG and MDRD in terms of bias, precision, accuracy, and the risk of misclassifying by two CKD stages. Results: In the chronic renal disease population, MDRD was more precise, safer and more accurate than CG at predicting the GFR, with two exceptions: CG was clearly superior in CKD patients with a normal serum creatinine (SCr) and results were discordant in patients with advanced renal failure. In diabetic populations with normal and near-normal GFR, the decline in renal function in diabetics was better screened by CG. In diabetics with renal impairment, MDRD is more accurate than CG. In healthy patients, in subjects with normal SCr and in elderly patients, MDRD was not superior. Based on the risk of misclassifying by ≧2 CKD stages, neither formula could be safely applied in diabetic, low body mass index, advanced liver disease, chronic heart failure, or hospitalized patients. Conclusions: CG still has an interest in screening the decline in renal function in subjects with normal SCr who are at risk, such as diabetics and stage 1 and 2 CKD patients, as well as healthy subjects enrolled in clinical trials and pharmacokinetic studies. Thus, it may be early to replace CG by MDRD in drug studies. CG still is the better formula in the elderly. Both formulas are not safe in some populations.

Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients

“…This is in the same range as previously reported [19] and disappeared using the Schwartz formula. The Cockcroft-Gault formula remains the favoured formula to estimate GFR in adult patients with normal serum creatinine but might be worse than other formulas like the modification of diet in renal disease formula in subjects with chronic kidney disease [21]. In our study correlation of the Cockcroft-Gault and Schwartz formula was poor ( r = 0.49), which highlights the dilemma that no formula for eCCL is sufficient to estimate renal function in a CF cohort consisting of children, adolescents, and adult patients.…”

Increased Microalbuminuria Risk in Male Cigarette Smokers: Results from the “Olivetti Heart Study” after 8 Years Follow-Up

“…However, CG formula is considered of interest in screening declining renal function in subjects with normal serum creatinine (SC) in order to investigate sample of population at risk [29]. Moreover, CG predicts mortality better than the CKD-EPI and MDRD in a recent study aiming to assess 1-year mortality prediction in patients with heart failure and concomitant atrial fibrillation [30].…”

Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation

“…6 In this study, the mean CCr was 54.7 6 26.3 mL/minute, and 63.1% of participants were judged as having renal dysfunction, which may mask the impact of renal dysfunction on functional outcome. The Cockcroft-Gault formula is useful in older patients for screening the decline of renal function, 28 but it is not safe in patients with a low BMI (eg, BMI ,21) 29 or in ill or hospitalized patients. 30 In this study, the mean BMI was 21.8 6 4.1, and 156 (45.3%) patients had a BMI of less than 21.…”